沃爾瑪旗下印度電商Flipkart就反壟斷調查向印度法庭提異議
美國零售巨擘沃爾瑪(Walmart)(WMT.US)旗下印度電商Flipkart,就印度競爭委員會進行反壟斷調查向當地法庭提出異議。《路透社》報道,Flipkart提交的法庭文件指,公司不應與美國電商亞馬遜(Amazon)(AMZN.US)獲相同對待,認爲當局對兩間公司提控的證據本質上有區別,又指當局及法院混淆亞馬遜與Flipkart的事實,及忽視兩者爲激烈的競爭對手。
Flipkart又指,印度競爭委員會在展開反壟斷調查前,亞馬遜與商戶之間的商業協議與Flipkart無關,當局應分開處理兩間公司的反壟斷指控。
報道指,印度法院料於未來數日就亞馬遜及Flipkart就反壟斷調查提出的反對發出書面指令。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.